Changsha DIALINE New Material Sci.&Tech. Co., Ltd. carries a market capitalization of 8.37B, placing it among publicly traded companies globally. Its enterprise value stands at 4.63B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.37B |
| Enterprise Value | 4.63B |
Changsha DIALINE New Material Sci.&Tech. Co., Ltd. currently has 396.05M shares outstanding.
| Shares Outstanding | 396.05M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 12.23, and the price-to-book ratio stands at 14.52.
| PE Ratio | N/A |
| PS Ratio | 12.23 |
| PB Ratio | 14.52 |
| P/TBV Ratio | 5.59 |
| P/FCF Ratio | 84.82 |
| P/OCF Ratio | N/A |
| EV / Sales | 12.77 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 73.26 |
Changsha DIALINE New Material Sci.&Tech. Co., Ltd. maintains a current ratio of 1.10, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.22, indicating elevated leverage, while an interest coverage ratio of -10.20 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.10 |
| Quick Ratio | 0.41 |
| Debt / Equity | 53.22 |
| Debt / EBITDA | -3.91 |
| Interest Coverage | -10.20 |
| Return on Equity (ROE) | -61.61 |
| Return on Assets (ROA) | -14.51 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.25 |
| Income Tax | -28.69M |
| Effective Tax Rate | N/A |
Changsha DIALINE New Material Sci.&Tech. Co., Ltd.'s stock has gained approximately 71.04216% over the past 52 weeks. The 50-day moving average sits at 20.04, while the 200-day moving average is 14.82.
| Beta (5Y) | N/A |
| 52-Week Price Change | 71.04216% |
| 50-Day Moving Average | 20.04 |
| 200-Day Moving Average | 14.82 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Changsha DIALINE New Material Sci.&Tech. Co., Ltd. generated 362.84M in revenue and converted that into -268.94M in net income, yielding earnings per share of -0.69. EBITDA reached -123.31M, while operating income came in at -123.31M.
| Revenue | 362.84M |
| Gross Profit | -48.78M |
| Operating Income | -123.31M |
| Pretax Income | -301.87M |
| Net Income | -268.94M |
| EBITDA | -123.31M |
| EBIT | -123.31M |
| Earnings Per Share (EPS) | -0.69 |
Changsha DIALINE New Material Sci.&Tech. Co., Ltd. holds 294.72M in cash and equivalents against 481.59M in total debt, resulting in a net debt position of 78.53M. Total book value stands at 305.58M, with working capital of 75.43M providing operational flexibility.
| Cash & Cash Equivalents | 294.72M |
| Total Debt | 481.59M |
| Net Debt | 78.53M |
| Equity (Book Value) | 305.58M |
| Book Value Per Share | 0.78 |
| Working Capital | 75.43M |
After subtracting -52.32M in capital expenditures, free cash flow totaled -52.32M - equivalent to -0.13 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -52.32M |
| Free Cash Flow | -52.32M |
| FCF Per Share | -0.13 |
Changsha DIALINE New Material Sci.&Tech. Co., Ltd. operates with a gross margin of -13.44, reflecting its pricing power and cost economics. The operating margin of -33.99 and net profit margin of -74.12 provide insight into operational efficiency.
| Gross Margin | -13.44 |
| Operating Margin | -33.99 |
| Pretax Margin | -83.20 |
| Profit Margin | -74.12 |
| EBITDA Margin | -33.99 |
The company's payout ratio of -4.88 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.03 |
| Dividend Yield | N/A |
| Payout Ratio | -4.88 |
| Shareholder Yield | 1.04 |
| FCF Yield | 1.18 |
Changsha DIALINE New Material Sci.&Tech. Co., Ltd.'s most recent stock split took place on May 13, 2024 with a 5:7 split ratio.
| Last Split Date | 5/13/2024 |
| Split Ratio | 5:7 |
Changsha DIALINE New Material Sci.&Tech. Co., Ltd. posts an Altman Z-Score of 3.16, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.16 |